基于属性的医学用于IgA肾病:危险因素组合影响肾脏预后
该研究分析日本全国回顾性队列中996例IgA肾病患者,评估年龄、性别、BMI、CKD分期、尿蛋白和尿潜血六种属性与危险因素的交互作用。低eGFR、高尿蛋白和高尿酸血症与不良肾脏预后相关,口服糖皮质激素和扁桃体切除术为保护因素。基于属性的分析揭示了关键风险修饰因素,支持分层治疗策略。
要点
- 低eGFR、高尿蛋白和高尿酸血症与不良肾脏预后相关。
- 口服糖皮质激素和扁桃体切除术为保护因素。
- 尿蛋白是最一致的预后预测因子,尤其在尿潜血≤2+患者中。
核心结论
- 基于属性的分析揭示了关键风险修饰因素,支持IgA肾病的分层治疗策略。
- 这些发现强调基于属性的医学在指导IgA肾病患者个性化诊疗中的潜力。
研究设计与样本
- 日本全国回顾性队列研究,纳入996例IgA肾病患者。
- 主要结局为启动肾脏替代治疗或血清肌酐升高至1.5倍。
- 评估六种预设属性:年龄、性别、体重指数、CKD分期、尿蛋白排泄和尿潜血。
- 采用Cox回归和Kaplan-Meier分析评估属性与危险因素的交互作用。
主要发现
- eGFR每升高10 mL/min/1.73 m²,风险比(HR)=0.87。
- 对数转换尿蛋白的HR=4.54。
- 高尿酸血症HR=1.64。
- 口服糖皮质激素HR=0.60,扁桃体切除术HR=0.44。
- 年龄和eGFR的预后效应在CKD 3期与1-2期相比出现反转。
临床怎么用
- 尿蛋白是最一致的预后预测因子,尤其在尿潜血≤2+的患者中。
- 糖皮质激素改善尿蛋白≥1 g/天患者的结局。
- 扁桃体切除术对尿潜血≥3+的患者有效。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND HYPOTHESIS: Attribute-based medicine emphasizes tailoring care to patient-specific characteristics. Immunoglobulin A nephropathy (IgAN), a heterogeneous glomerular disease, presents varying risks across subgroups. We hypothesized that an attribute-based medicine approach could identify residual risk factors and inform personalized strategies. METHODS: We analysed data from 996 patients from the Japanese Nationwide Retrospective Cohort Study in IgAN. The primary outcome was kidney replacement therapy initiation or a 1.5-fold increase in serum creatinine. Six pre-specified attributes were assessed: age, sex, body mass index (BMI), chronic kidney disease (CKD) stage, urinary protein excretion (U-Prot) and urine occult blood (U-OB). Cox regression and Kaplan-Meier analyses were performed to evaluate interactions between attributes and risk factors. RESULTS: Poor kidney prognosis was associated with lower estimated glomerular filtration rate (eGFR) [per 10 mL/min/1.73 m² increase, hazard ratio (HR) = 0.87], higher U-Prot (log-transformed HR = 4.54) and hyperuricaemia (HR = 1.64), while oral corticosteroids (HR = 0.60) and tonsillectomy (HR = 0.44) were protective factors. Significant interactions included the following: hyperuricaemia with BMI <22 kg/m²; hypertension with female sex; eGFR and age with CKD stage; U-Prot with age, eGFR and corticosteroid use; and U-Prot with U-OB. Prognostic effects of age and eGFR were reversed for CKD stage 3 compared with stages 1-2. U-Prot was the most consistent predictor of poor prognosis, especially in patients with U-OB ≤2+. Corticosteroids improved outcomes in patients with U-Prot ≥1 g/day, while tonsillectomy was effective in those with U-OB ≥3+. CONCLUSION: Attribute-based analysis revealed critical risk modifiers and supported stratified treatment strategies for IgAN. These findings underscore the potential of attribute-based medicine in guiding personalized care for patients with IgAN.
引用
- Kataoka H, Manabe S, Moriyama T, et al. Attribute-based medicine for IgA nephropathy: risk factor constellations influence kidney prognosis. Nephrol Dial Transplant. 2026. PMID: 40864144. doi:10.1093/ndt/gfaf170
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。